Richard G. LeBaron

Publication Activity (10 Years)

Years Active: 2011-2017
Publications (10 Years): 2

Top Topics

Clinical Applications

Diabetes Mellitus

Medical Diagnostic

Top Venues

Int. J. Knowl. Discov. Bioinform.

Publications

Clyde F. Phelix, Greg Villareal, Richard G. LeBaron, Dawnlee J. Roberson
Integrating -omics information with biosimulations to assist diagnosis and treatment of diabetes mellitus in silico. BHI (2017)
Clyde F. Phelix, Allen K. Bourdon, Greg Villareal, Richard G. LeBaron
Modeling non-clinical and clinical drug tests in Gaucher disease. EMBC (2016)
Charles D. Hammack, George Perry, Richard G. LeBaron, Greg Villareal, Clyde F. Phelix
Low Dose Pioglitazone Attenuates Oxidative Damage in Early Alzheimer's Disease by Binding mitoNEET: Transcriptome-To-Reactome™ Biosimulation of Neurons. Int. J. Knowl. Discov. Bioinform. 5 (1) (2015)
Clyde F. Phelix, Greg Villareal, Richard G. LeBaron, Dawnlee J. Roberson
Biomarkers from biosimulations: Transcriptome-to-reactome™ Technology for individualized medicine. EMBC (2014)
Clyde F. Phelix, Richard G. LeBaron, Dawnlee J. Roberson, Rosa E. Villanueva, Greg Villareal, Omid B. Rahimi, Sandra Siedlak, Xiongwei Zhu, George Perry
In Vivo and In Silico Evidence: Hippocampal Cholesterol Metabolism Decreases with Aging and Increases with Alzheimers Disease - Modeling Brain Aging and Disease. ICDM Workshops (2011)
Clyde F. Phelix, Richard G. LeBaron, Dawnlee J. Roberson, Rosa E. Villanueva, Greg Villareal, Omid B. Rahimi, Sandra Siedlak, Xiongwei Zhu, George Perry
Transcriptome-To-Metabolome™ Biosimulation Reveals Human Hippocampal Hypometabolism with Age and Alzheimer's Disease. Int. J. Knowl. Discov. Bioinform. 2 (2) (2011)